key: cord-0896911-9ujb9kbn authors: Barabutis, Nektarios title: P53 in acute respiratory distress syndrome date: 2020-09-04 journal: Cell Mol Life Sci DOI: 10.1007/s00018-020-03629-1 sha: ad9efa1ee852da43a1c660b4d28b47ad8319b3d6 doc_id: 896911 cord_uid: 9ujb9kbn P53 is a tumor suppressor protein, associated with strong anti-inflammatory activities. Recent evidence suggest that this transcription factor counteracts lung inflammatory diseases, including the lethal acute respiratory distress syndrome. Herein we provide a brief discussion on the relevant topic. glycolysis [3] . The activation of one of those proteins results in the deactivation of the other, hence inhibition of NF-κΒ results in the activation of P53 functions [4] . Chronic infections by mycoplasma as well as NF-κΒ-activating peptides reduce P53, contributing to the progression of malignant transformations [5] . P53 is required for the repression of NF-κB by the glucocorticoid receptor [6] , and P53 deficiency in mice was shown to potentiate the LPS-induced inflammation [7] . Moreover, P53 inhibits inflammation by antagonizing NF-κB [8] . The anti-inflammatory activities of P53 in human pathophysiology are not limited to cancer tissues. Indeed, it appears that this transcription factor exerts the capacity to protect against the LPS-induced lung endothelial hyperpermeability, by suppressing the inflammatory RhoA/MLC2 pathway, thus reducing the formation of the F-actin fibers [9] . Further studies revealed that P53 enhances endothelial barrier function by suppressing the actin-severing activity of cofilin, as well as by mediating the opposing activities of Rac1/RhoA both in vitro and in mutant mice overexpressing P53 [10] . Cofilin is the downstream target of the Rac1/p21-activated kinase/LIMK axis [11, 12] , and has been associated with hyper-permeability responses [13] . Activation of this molecular cascade by P53 inducers (i.e. Hsp90 inhibitors) phosphorylates, hence deactivates, cofilin [10] . On the other hand, this endothelial defender (P53) [14] suppresses the RhoA pathway via p190RhoGAP induction. This is a Rho family GTPase-activating protein which regulates actin stress fiber dynamics via hydrolysis of Rho-GTP, and it is a suppressor of the RhoA/MLC2 pathway [15] . The phosphorylation of P53 is modulated by both LPS and Hsp90 inhibitors, indicating that activated (phospho) P53 is involved in lung hyper-permeability responses [16] . Furthermore, studies in bovine lung microvascular cells indicated that the protective effects of P53 are associated with the suppression of the inflammatory apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref1) [17] ; and the reduction of the reactive oxygen species [18] . APE1/Ref-1 is a redox signalling factor, which regulates the DNA binding activities of NF-κB and hypoxia-inducible transcription factor 1α [19] . Thus, it exerts a major role in promoting inflammation and serves as a therapeutic target in human disease [20] . Interestingly, this endothelium defender (P53) [14] has been shown to be a direct target of the unfolded protein response (UPR) [21, 22] . UPR acts to restore impaired functions of damaged tissues [23] , including the lungs [24, 25] and affects P53 levels in a positive manner. In lung bovine cells the UPR inductors Brefeldin A, dithiothreitol, and thapsigargin induced P53, while the UPR inhibitors N-acetyl cysteine, kifunensine, and ATP-competitive IRE1α kinaseinhibiting RNase attenuator produced the opposite effects. Hence P53 may mediate, or even initiate, UPR-mediated responses towards the maintenance of lung homeostasis [26] . This multifaceted maestro (P53) is strongly involved in the protective effects of Hsp90 inhibitors and GHRH antagonists in the lung microvasculature [27, 28] . Those anti-cancer and anti-inflammatory agents induce UPR both in vivo and in vitro. Hence, the existence of a new molecular network in the context of P53/UPR/Hsp90 [29] , which operates towards the repair of the severely inflamed lungs, is highly possible [30, 31] . Pharmacological "fine-tuning" of that meticulously orchestrated network, may deliver novel ways to restore respiratory functions in the hospitalized ARDS patients. Unfolded protein response in acute respiratory distress syndrome P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa and NF-kappaB: different strategies for responding to stress lead to a functional antagonism Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors and the carcinogenicity of chronic inflammation Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor P53 deficiency potentiates LPS-induced acute lung injury in vivo is a suppressor of inflammatory response in mice protects against LPS-induced lung endothelial barrier dysfunction Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition Actin realignment and cofilin regulation are essential for barrier integrity during shear stress ADF/cofilin: a functional node in cell biology Functions of cofilin in cell locomotion and invasion P53: the endothelium defender RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity Hsp90 inhibitors suppress P53 phosphorylation in LPS-induced endothelial inflammation P53 supports endothelial barrier function via APE1/Ref1 suppression Barabutis N (2020) P53 regulates the redox status of lung endothelial cells Apurinic/apyrimidinic endonuclease 1 regulates inflammatory response in macrophages APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions Losing p53 loosens up ERstress Alternative mechanisms of p53 action during the unfolded protein response Unfolded protein response in cardiovascular disease Unfolded protein response in lung health and disease Pharmacological targeting of the unfolded protein response for disease intervention Unfolded protein response regulates P53 expression in the pulmonary endothelium Heat shock protein 90 inhibition in the inflamed lungs GHRH antagonists support lung endothelial barrier function The highly interrelated GHRH, p53, and Hsp90 universe Hsp90 inhibitors induce the unfolded protein response in bovine and mice lung cells Growth hormone releasing hormone in the unfolded protein response context Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations